Drugs / Fluzone Quadrivalent vaccine
Fluzone Quadrivalent vaccine
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT03898986 | Oct 2019 → Dec 2023 | influenza | Stanford University | Completed | No outcome recorded |
| Phase 1 | NCT03088904 | Oct 2014 → Dec 2018 | influenza | Stanford University | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT04551677 | Sep → Dec 2020 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT04109222 | Sep → Dec 2019 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT03617523 | Sep → Nov 2018 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT03308825 | Sep → Nov 2017 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT02258334 | Oct → Nov 2014 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02290509 Comparator | Oct 2014 → May 2015 | influenza | Protein Sciences Corporation | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Quadrivalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258334 ↗ |
| Known as | Fluzone Quadrivalent | “Fluzone® Quadrivalent” NCT04551677 ↗ |
| Known as | Fluzone Quadrivalent, No Preservative | “Fluzone® Quadrivalent, No Preservative” NCT04109222 ↗ |
| Known as | Inactivated Influenza Vaccine (IIV4) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03898986 ↗ |
| Modality | Vaccine | “a standard-dose, egg-grown, quadrivalent-inactivated influenza vaccine (IIV4)” PMID 28968871 ↗ Dec 2017 |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT02258334 ↗ |